Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149062 | PMC |
| http://dx.doi.org/10.1016/j.jdcr.2016.08.016 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dermatological conditions in the intensive care unit at a tertiary care hospital in Riyadh, Saudi Arabia.
Saudi Med J
August 2024
From the College of Medicine (Altammami, Alswayed, AlJasser, Alkhodair), King Saud bin Abdulaziz University for Health Sciences, from the Department of Dermatology (AlJasser, Alkhodair), King Abdullah International Medical Research Center, from the Division of Dermatology (AlJasser), Ministry of National Guard Health Affairs, and from the Division of Pediatric Dermatology (Alkhodair), Department of Pediatrics, King Abdullah Specialist Children's Hospital, Riyadh, Kingdom of Saudi Arabia.
Article Synopsis
- The study aimed to examine skin conditions in patients admitted to the ICU, analyzing both those who developed dermatological issues during their stay and those whose conditions necessitated ICU care.
- A total of 344 patients were reviewed, revealing 365 distinct dermatological conditions, with the most common issues being skin infections, inflammatory diseases, and drug reactions.
- Key findings highlighted morbilliform drug eruption, contact dermatitis, and vasculitis as the top dermatological disorders observed among ICU patients.
A case report of squamous cell carcinoma mimicking interdigital intertrigo.
Oxf Med Case Reports
July 2024
Department of Dermatology and Venereology, Mohammed VI University Hospital, M3MF+GCG, La Nouvelle Ville Ibn Batouta, Tangier, Morocco.
Article Synopsis
- Squamous cell carcinoma (SCC) is a common type of skin cancer that can affect the nails, exemplified by a 60-year-old male patient who developed a painful ulcer in his foot due to a prior misdiagnosis of a fungal infection.
- Dermatological examination showed characteristics of SCC, and although the initial biopsy indicated keratoacanthoma, it did not reveal malignant features, leading to the eventual identification of moderately differentiated SCC in a follow-up biopsy.
- Successful surgical resection was performed to treat the SCC, highlighting the importance of accurate pathology understanding and biopsy techniques in preventing progression of this form of skin cancer.
Article Synopsis
- Drug reactions are a significant concern in anti-cancer therapies, with less common risks like toxic erythema linked to chemotherapy.
- Patients undergoing cancer treatments have weakened immune systems, making them more prone to infections.
- The text discusses a rare case where a patient's skin condition evolved into a severe reaction after starting treatment with bevacizumab and lorlatinib, leading to a combined skin infection.
Carcinoma erysipelatoides (CE) is a rare clinical manifestation of cutaneous metastasis, which mimics inflammatory conditions such as erysipelas. Depending on the site of the originating tumour, unusual manifestations involving different sites of the body may occur. We herein report a case of a 60-year-old female patient with metastatic endometrial carcinoma presenting as CE of the abdominal skin and the inguinal folds.
View Article and Find Full Text PDFToxic erythema of chemotherapy secondary to gemcitabine and paclitaxel.
Dermatol Online J
September 2020
Department of Dermatology, Lewis Katz School of Medicine, Philadelphia, PA.
Toxic erythema of chemotherapy (TEC) is an infrequently reported cutaneous condition, with diagnosis predominately based on clinical presentation, histologic findings, and known reported associations. Therefore, it is important to both recognize common presentations of TEC and be mindful of chemotherapeutic agents associated with this cutaneous side effect to prevent misdiagnosis and prolonged time to treatment. Herein, we present a patient with TEC occurring in intertriginous skin (malignant intertrigo) with classic clinical and histologic findings.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!